Effect of high-field iMRI guided resection in cerebral glioma surgery: A randomized clinical trial

Abstract

Background

Extent of resection (EOR) in glioma contributes to longer survival. The purpose of NCT01479686 was to prove whether intraoperative magnetic resonance imaging (iMRI) increases EOR in glioma surgery and benefit survival.

Methods

Patients were randomized (1:1) to receive the iMRI (n=161) or the conventional neuronavigation (n=160). The primary endpoint was gross total resection (GTR); secondary outcomes reported were progression-free survival (PFS), overall survival (OS), and safety.

Results

188 high-grade gliomas (HGGs) and 133 low-grade gliomas (LGGs) were enrolled. GTR was 83.85% in the iMRI group vs. 50.00% in the control group (P<0.0001). In 321 patients, the median PFS (mPFS) was 65.12 months in the iMRI group and 61.01 months in the control group (P=0.0202). For HGGs, mPFS was improved in the iMRI group (19.32 vs. 13.34 months, P=0.0015), and a trend of superior OS compared with control was observed (29.73 vs. 25.33 months, P=0.1233). In the predefined eloquent area HGG subgroup, mPFS, and mOS were 20.47 months and 33.58 months in the iMRI vs. 12.21 months and 21.16 months in the control group (P=0.0098; P=0.0375, respectively). From the exploratory analyses of HGGs, residual tumor volume (TV) <1.0 cm³ decreased the risk of survival (mPFS: 18.99 vs. 9.43 months, P=0.0055; mOS: 29.77 vs. 18.10 months, P=0.0042). LGGs with preoperative (pre-OP) TV>43.1 cm³ and postoperative (post-OP) TV>4.6 cm³ showed worse OS (p=0.0117).

Conclusions

It showed that iMRI significantly increased EOR and indicated survival benefits for HGGs, particularly eloquent HGGs. Residual TV in either HGGs or LGGs is a prognostic factor for survival.